Javascript must be enabled to continue!
Nlrp3 inflammasome in the heart of hypothyroid mice
View through CrossRef
Cardiovascular diseases are the most common cause of death worldwide and thyroid diseases are frequently associated with cardiac function impairment. Hypothyroidism is related to dilation of the ventricles, fibrosis and consequent reduction in cardiac contractility, as well as an increased risk of heart failure. Recent studies have demonstrated the participation of the NLRP3 inflammasome, an important mechanism of the innate immune response, in cardiovascular diseases, such as myocardial infarction and atherosclerosis. There is evidence in the literature that hypothyroidism is accompanied by increased levels of cytokines and oxidative stress, processes that can activate the inflammasome. The aim of the present study is to evaluate the role of the NLRP3 inflammasome in the heart of hypothyroid mice. For this, Wild Type (WT) mice treated with methimazole (0.05% added to drinking water for 12 weeks) were used (N=4-6). All protocols used in this study were approved by the Animal Ethics Committee of the Institute of Biomedical Sciences (9768300119). Thyroid hormones were quantified by bead-based immunoassay Luminex to confirm the efficacy of experimental model. Fibrosis was analyzed by histology, using picrosirius red staining. Cardiac function was evaluated in mice by plethysmography and in isolated hearts after ischemia/reperfusion by the Langendorff method. Protein expression of NLRP3 inflammasome components was evaluated by Western Blotting. Data were analyzed by one-way ANOVA or Student's t test. Results are presented as mean ± standard error of the mean, and p<0.05 was considered statistically significant. Increased TSH levels (control=92±33, hypo=369±62 (pg/ml)) and reduced T4 (control=1.16±0.38, hypo=0.03±0.01 (ng/ml)) confirmed the hypothyroid status of mice. The heart weight/tibial length ratio and fibrosis were not altered by hypothyroidism. Heart rate was reduced in hypothyroid mice (control=663±27, hypo=541±28 (bpm)). No differences were detected in the cardiac function parameters after Ischemia-Reperfusion injury: left ventricular developed pressure (LVDP), maximum (dP/dtmax) or minimum first derivative (dP/dtmin). Concerning to inflammasome, NLRP3 expression was reduced (control=100±16, hypo=29±14 (%)) and pro-caspase 1 increased (control=100±17, hypo=259±43 (%)) in hypothyroid hearts. These preliminary results showed characterization data for experimental hypothyroidism and that this condition can modulate inflammasome expression. Additional experiments are underway to confirm the role of the NLRP3 inflammasome on cardiac function in hypothyroid mice. FAPESP (grants nº 2021/06151-7 and 2019/17031-2) This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.
American Physiological Society
Title: Nlrp3 inflammasome in the heart of hypothyroid mice
Description:
Cardiovascular diseases are the most common cause of death worldwide and thyroid diseases are frequently associated with cardiac function impairment.
Hypothyroidism is related to dilation of the ventricles, fibrosis and consequent reduction in cardiac contractility, as well as an increased risk of heart failure.
Recent studies have demonstrated the participation of the NLRP3 inflammasome, an important mechanism of the innate immune response, in cardiovascular diseases, such as myocardial infarction and atherosclerosis.
There is evidence in the literature that hypothyroidism is accompanied by increased levels of cytokines and oxidative stress, processes that can activate the inflammasome.
The aim of the present study is to evaluate the role of the NLRP3 inflammasome in the heart of hypothyroid mice.
For this, Wild Type (WT) mice treated with methimazole (0.
05% added to drinking water for 12 weeks) were used (N=4-6).
All protocols used in this study were approved by the Animal Ethics Committee of the Institute of Biomedical Sciences (9768300119).
Thyroid hormones were quantified by bead-based immunoassay Luminex to confirm the efficacy of experimental model.
Fibrosis was analyzed by histology, using picrosirius red staining.
Cardiac function was evaluated in mice by plethysmography and in isolated hearts after ischemia/reperfusion by the Langendorff method.
Protein expression of NLRP3 inflammasome components was evaluated by Western Blotting.
Data were analyzed by one-way ANOVA or Student's t test.
Results are presented as mean ± standard error of the mean, and p<0.
05 was considered statistically significant.
Increased TSH levels (control=92±33, hypo=369±62 (pg/ml)) and reduced T4 (control=1.
16±0.
38, hypo=0.
03±0.
01 (ng/ml)) confirmed the hypothyroid status of mice.
The heart weight/tibial length ratio and fibrosis were not altered by hypothyroidism.
Heart rate was reduced in hypothyroid mice (control=663±27, hypo=541±28 (bpm)).
No differences were detected in the cardiac function parameters after Ischemia-Reperfusion injury: left ventricular developed pressure (LVDP), maximum (dP/dtmax) or minimum first derivative (dP/dtmin).
Concerning to inflammasome, NLRP3 expression was reduced (control=100±16, hypo=29±14 (%)) and pro-caspase 1 increased (control=100±17, hypo=259±43 (%)) in hypothyroid hearts.
These preliminary results showed characterization data for experimental hypothyroidism and that this condition can modulate inflammasome expression.
Additional experiments are underway to confirm the role of the NLRP3 inflammasome on cardiac function in hypothyroid mice.
FAPESP (grants nº 2021/06151-7 and 2019/17031-2) This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format.
There are no additional versions or additional content available for this abstract.
Physiology was not involved in the peer review process.
Related Results
S3.4d The role of NLRP3 inflammasome in host defense during Talaromyces marneffei infection
S3.4d The role of NLRP3 inflammasome in host defense during Talaromyces marneffei infection
Abstract
S3.4 Free oral paper session, September 21, 2022, 4:45 PM - 6:15 PM
Talaromyces (Penicillium) marneffei (T. marneffei) ...
The Transcription Factor Gfi1 Negatively Regulates NLRP3 inflammasome-Mediated IL-1β Secretion in Macrophages
The Transcription Factor Gfi1 Negatively Regulates NLRP3 inflammasome-Mediated IL-1β Secretion in Macrophages
Abstract
Background: IL-1β secretion is tightly controlled at the transcriptional and post-translational levels. The NLRP3 inflammasome, a multiprotein complex compo...
RACK1 mediates NLRP3 inflammasome activation during Pasteurella multocida infection
RACK1 mediates NLRP3 inflammasome activation during Pasteurella multocida infection
Abstract
Pasteurella multocida is gram-negative bacteria that causes serious diseases in a wide range of animal species. Inflammasome as an intracellular multimolecular pro...
GW24-e1138 The Mitochondrial DAMP fMLP activates Nlrp3 Inflammasome which Promotes Angiogenesis after Hindlimb Ischemia
GW24-e1138 The Mitochondrial DAMP fMLP activates Nlrp3 Inflammasome which Promotes Angiogenesis after Hindlimb Ischemia
Objectives
Peripheral arterial disease (PAD) is a systemic inflammatory disorder that affect millions of people worldwide. The secretion of Interleukin-1 beta (IL...
HMGB1-induced NLRP3 Inflammasome Participating in Platelet Activation and Thrombocytopenia in Heatstroke
HMGB1-induced NLRP3 Inflammasome Participating in Platelet Activation and Thrombocytopenia in Heatstroke
Abstract
Background: Previous studies have suggested that NOD-like receptor family pyrin domain containing 3 (NLRP3) inflammasome plays an important role in heat stroke (HS...
Effect of miR-223-3p on cell pyroptosis in myelodysplastic syndrome and its
mechanism via regulating the expression of NLRP3
Effect of miR-223-3p on cell pyroptosis in myelodysplastic syndrome and its
mechanism via regulating the expression of NLRP3
This study aimed to investigate the regulatory mechanism of the miR-223-3p/NLRP3 signaling axis in
the progression of myelodysplastic syndrome (MDS). For this purpose, SKM-1 cells ...
The NLRP3 Inflammasome as a Target for Antiinflammatory Drugs
The NLRP3 Inflammasome as a Target for Antiinflammatory Drugs
The Nod-like receptor protein 3 (NLRP3) inflammasome plays a vital role in
the nonspecific immune response to inflammatory triggers such as cellular infections,
injury, or stressor...
NLRP3 inflammasome inhibitor MCC950 attenuates primary dysmenorrhea in mice via the NF-κB/COX-2/PG pathway
NLRP3 inflammasome inhibitor MCC950 attenuates primary dysmenorrhea in mice via the NF-κB/COX-2/PG pathway
Abstract
Background: Primary dysmenorrhea (PD) constitutes a common gynecological disease among young women. The NLRP3 inflammasome may be activated and expressed in PD, bu...

